Burden of pneumocystis pneumonia in HIV-infected adults in sub-Saharan Africa: A systematic review and meta-analysis

BMC Infectious Diseases

Volumn 16, Issue 1, 2016, Pages

  Wasserman, Sean ^a   Engel, Mark E ^a   Griesel, Rulan ^a   Mendelson, Marc ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

HIV associated opportunistic infection; PCP; Pneumocystis pneumonia; Respiratory disease in HIV

Indexed keywords

ADULT; AFRICA SOUTH OF THE SAHARA; ARTICLE; CASE FATALITY RATE; CAUSE OF DEATH; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; LUNG LAVAGE; MORTALITY; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; PREVALENCE; SPUTUM; SYSTEMATIC REVIEW; AFRICA; AIDS-RELATED OPPORTUNISTIC INFECTIONS; COMPLICATION; META ANALYSIS; PNEUMOCYSTIS; PNEUMONIA, PNEUMOCYSTIS; SEROEPIDEMIOLOGY; VIROLOGY;

AFRICA; AFRICA SOUTH OF THE SAHARA; AIDS-RELATED OPPORTUNISTIC INFECTIONS; HIV INFECTIONS; HUMANS; PNEUMOCYSTIS; PNEUMONIA, PNEUMOCYSTIS; POLYMERASE CHAIN REACTION; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; SPUTUM;

EID: 84986568307     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-016-1809-3     Document Type: Article

References (36)

1. Masur H, Michelis MA, Greene JB, Onorato I, Stouwe RA, Holzman RS, et al. An outbreak of community-acquired Pneumocystis Carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med. 1981;305(24):1431-8. doi: 10.1056/Nejm198112103052402.
2. Hay JW, Osmond DH, Jacobson MA. Projecting the medical costs of aids and arc in the United States. J Acquir Immune Defic Syndr. 1988;1(5):466-85.
3. Morris A, Lundgren JD, Masur H, Walzer PD, Hanson DL, Frederick T, et al. Current epidemiology of Pneumocystis pneumonia. Emerg Infect Dis. 2004;10(10):1713-20. doi: 10.3201/Eid1010.030985.
4. Kelley CF, Checkley W, Mannino DM, Franco-Paredes C, Del Rio C, Holguin F. Trends in hospitalizations for aids-associated Pneumocystis Jirovecii pneumonia in the United States (1986 to 2005). Chest. 2009;136(1):190-7. doi: 10.1378/Chest.08-2859.
5. World Health Organization. Global tuberculosis report 2014. Geneva: World Health Organization; 2014.
6. Holmes CB, Losina E, Walensky RP, Yazdanpanah Y, Freedberg KA. Review of human immunodeficiency virus type 1-related opportunistic infections in Sub-Saharan Africa. Clin Infect Dis. 2003;36(5):652-62. doi: 10.1086/367655. Epub 2003/02/21.
7. Serwadda D, Goodgame R, Lucas S, Kocjan G. Absence of Pneumocystosis in Ugandan aids patients. Aids. 1989;3(1):47-8.
8. Elvin KM, Lumbwe CM, Luo NP, Bjorkman A, Kallenius G, Linder E. Pneumocystis Carinii is not a major cause of pneumonia in HIV infected patients in Lusaka, Zambia. Trans R Soc Trop Med Hyg. 1989;83(4):553-5.
9. Karstaedt AS. Aids--The Baragwanath experience. Part III. HIV infection in adults At Baragwanath Hospital. S Afr Med J. 1992;82(2):95-7.
10. Maartens G. Opportunistic infections associated with HIV infection in Africa. Oral Dis. 2002;8 Suppl 2:76-9. Epub 2002/08/08.
11. Zar HJ, Maartens G, Wood R, Hussey G. Pneumocystis Carinii pneumonia in HIV-infected patients in Africa--an important pathogen? S Afr Medl J = Suid-Afrikaanse Tydskrif Vir Geneeskunde. 2000;90(7):684-8. Epub 2000/09/14.
12. Russian DA, Kovacs JA. Pneumocystis Carinii in Africa: an emerging pathogen? Lancet. 1995;346(8985):1242-3. Epub 1995/11/11.
13. Lowe DM, Rangaka MX, Gordon F, James CD, Miller RF. Pneumocystis Jirovecii pneumonia in tropical and low and middle income countries: a systematic review and meta-regression. Plos One. 2013;8(8):E69969. doi: 10.1371/Journal.Pone.0069969.
14. Siedner MJ, Ng CK, Bassett IV, Katz IT, Bangsberg DR, Tsai AC. Trends in CD4 count at presentation to care and treatment initiation in Sub-Saharan Africa, 2002-2013: A meta-analysis. Clin Infect Dis. 2014. doi: 10.1093/Cid/Ciu1137. Epub 2014/12/18.
15. World Health Organization. Antiretroviral therapy (ART) coverage among all age groups. Available at: http://www.who.int/gho/hiv/epidemic_response/ART_text/en/. Accessed 31 Aug 2016.
16. Nkinin SW, Daly KR, Walzer PD, Ndzi ES, Asonganyi T, Respaldiza N, et al. Evidence for high prevalence of Pneumocystis Jirovecii exposure among Cameroonians. Acta Trop. 2009;112(2):219-24. doi: 10.1016/J.Actatropica.2009.07.030.
17. Smulian AG, Sullivan DW, Linke MJ, Halsey NA, Quinn TC, MacPhail AP, et al. Geographic variation in the humoral response to Pneumocystis Carinii. J Infect Dis. 1993;167(5):1243-7.
18. Lucas SB, Peacock CS, Hounnou A, Brattegaard K, Koffi K, Honde M, et al. Disease in children infected with HIV in Abidjan, Cote D'ivoire. BMJ. 1996;312(7027):335-8.
19. Ruffini DD, Madhi SA. The high burden of Pneumocystis Carinii pneumonia in African HIV-1-infected children hospitalized for severe pneumonia. Aids. 2002;16(1):105-12. Epub 2001/12/13.
20. Madhi SA, Petersen K, Madhi A, Khoosal M, Klugman KP. Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children. Clin Infect Dis. 2000;31(1):170-6. doi: 10.1086/313925. Epub 2000/07/29.
21. Fisk DT, Meshnick S, Kazanjian PH. Pneumocystis Carinii pneumonia in patients in the developing world who have acquired immunodeficiency syndrome. Clin Infect Dis. 2003;36(1):70-8. doi: 10.1086/344951.
22. Wasserman S, Engel ME, Mendelson M. Burden of Pneumocystis pneumonia in HIV-infected adults in Sub-Saharan Africa: protocol for a systematic review. Syst Rev. 2013;2:112. doi: 10.1186/2046-4053-2-112. Epub 2013/12/18.
23. World Health Organization. Who case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva: World Health Organization; 2007.
24. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-58. doi: 10.1002/Sim.1186. Epub 2002/07/12.
25. Batungwanayo J, Taelman H, Lucas S, Bogaerts J, Alard D, Kagame A, et al. Pulmonary disease associated with the human immunodeficiency virus in Kigali, Rwanda. A fiberoptic bronchoscopic study of 111 cases of undetermined etiology. Am J Respir Crit Care Med. 1994;149(6):1591-6. doi: 10.1164/Ajrccm.149.6.8004318. Epub 1994/06/01.
26. Kamanfu G, Mlika-Cabanne N, Girard PM, Nimubona S, Mpfizi B, Cishako A, et al. Pulmonary complications of human immunodeficiency virus infection in Bujumbura, Burundi. Am Rev Respir Dis. 1993;147(3):658-63. doi: 10.1164/Ajrccm/147.3.658. Epub 1993/03/01.
27. Abouya YL, Beaumel A, Lucas S, Dago-Akribi A, Coulibaly G, N'Dhatz M, et al. Pneumocystis Carinii Pneumonia. An uncommon cause of death in African patients with acquired immunodeficiency syndrome. Am Rev Respir Dis. 1992;145(3):617-20. doi: 10.1164/Ajrccm/145.3.617. Epub 1992/03/01.
28. Buchacz K, Baker RK, Palella FJ, Jr., Chmiel JS, Lichtenstein KA, Novak RM, et al. Aids-defining opportunistic illnesses in us patients, 1994-2007: A cohort study. Aids. 2010;24(10):1549-59. doi: 10.1097/Qad.0b013e32833a3967. Epub 2010/05/27.
29. Antiretroviral Therapy Cohort Collaboration, Mocroft A, Sterne JA, Egger M, May M, Grabar S, et al. Variable impact on mortality of aids-defining events diagnosed during combination antiretroviral therapy: not all aids-defining conditions are created equal. Clin Infect Dis. 2009;48(8):1138-51. doi: 10.1086/597468.
30. de Armas Rodriguez Y, Wissmann G, Muller AL, Pederiva MA, Brum MC, Brackmann RL, et al. Pneumocystis Jirovecii pneumonia in developing countries. Parasite (Paris, France). 2011;18(3):219-28. Epub 2011/09/07.
31. Roux P, Lavrard I, Poirot JL, Chouaid C, Denis M, Olivier JL, et al. Usefulness of PCR for detection of Pneumocystis Carinii DNA. J Clin Microbiol. 1994;32(9):2324-6. Epub 1994/09/01.
32. Harris JR, Marston BJ, Sangrujee N, DuPlessis D, Park B, et al. Cost-effectiveness analysis of diagnostic options for Pneumocystis pneumonia (PCP). Plos One. 2011;6(8):E23158. doi: 10.1371/Journal.Pone.0023158.
33. Wood BR, Komarow L, Zolopa AR, Finkelman MA, Powderly WG, Sax PE. Test performance of blood beta-glucan for Pneumocystis Jirovecii pneumonia in patients with aids and respiratory symptoms. Aids (London, England). 2013;27(6):967-72. doi: 10.1097/Qad.0b013e32835cb646.
34. Straetemans M, Glaziou P, Bierrenbach AL, Sismanidis C, van der Werf MJ. Assessing tuberculosis case fatality ratio: a meta-analysis. Plos One. 2011;6(6):E20755. doi: 10.1371/Journal.Pone.0020755.
35. Scott JAG, Hall AJ, Muyodi C, Lowe B, Ross M, Chohan B, et al. Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya. Lancet. 2000;355(9211):1225-30. doi: 10.1016/S0140-6736(00)02089-4.
36. Walzer PD, Evans HE, Copas AJ, Edwards SG, Grant AD, Miller RF. Early predictors of mortality from Pneumocystis Jirovecii pneumonia in HIV-infected patients: 1985-2006. Clin Infect Dis. 2008;46(4):625-33. doi: 10.1086/526778. Epub 2008/01/15.